Keeping Clients and Plan Members Informed
As the outbreak of the coronavirus (COVID-19) continues to evolve, CVS Health is committed to safeguarding our clients, plan members, customers, and colleagues.
In order for CVS Health to respond in a coordinated and timely manner, we have convened our internal expert Emergency Response & Resiliency Team and Infectious Disease Response Teams. These teams are actively monitoring the current international and domestic environment for coronavirus-related risks and are preparing CVS Health accordingly.
Specifically, these teams are:
- Collaborating with partners across CVS Health to help bolster business unit preparation and continuity, with a focus on meeting the needs of the consumers and other customers we serve, if and when warranted.
- Working with external public health and other stakeholders, including the Centers for Disease Control and Prevention (CDC), to boost awareness of CVS Health’s emergency preparedness efforts and capabilities.
MinuteClinic Preparedness for Patients with COVID-19 Symptoms
 |
CVS Health and MinuteClinic are collaborating closely with local health departments related to COVID-19. Patients presenting symptoms of upper-respiratory tract illnesses will be asked about their recent travel history and relevant risk factors to determine their risk of exposure to COVID-19 will be evaluated. These visits may also include recommending further consult with a physician to determine if a higher level of care is required. |
 |
MinuteClinic also offers patients the opportunity to request a Video Visit in 40 states and Washington, D.C. Virtual care options such as video visits can be an effective way to evaluate and treat viruses from the comfort of one’s home, while minimizing exposure to other potentially contagious viruses. |
Addressing Potential Drug Shortages
We are closely monitoring the global pharmaceutical manufacturing environment and working with our suppliers to ensure we can continue filling prescriptions for our pharmacy patients and plan members at CVS Health. We are actively managing our supply to ensure our ability to continue to fill prescriptions in our retail, mail and specialty pharmacies. As always, we encourage plan members to refill maintenance medications in a timely manner.
In addition to CVS Health’s monitoring, the Food and Drug Administration (FDA) is closely monitoring medications that are made in China or rely solely on active pharmaceutical ingredients from China. The agency also said it has reminded more than 180 manufacturers to notify the FDA of any potential supply chain disruptions.
Given the evolving nature of the COVID-19 outbreak, we will continue to monitor the situation and work with our suppliers to address issues as they arise. We will alert clients to potential disruptions and share our contingency plans to address them.
Keeping Your Plan Members Healthy
We have and will continue to develop a number of resources to inform your plan members about COVID-19 risks, symptoms, preparedness and prevention. We encourage all plan members to remain abreast of the situation by following updates from the CDC, as well as taking preventative health precautions to stay healthy.
 |
Follow updates from the CDC and WHO organizations:The CDC Coronavirus Website The World Health Organization Coronavirus Website |
 |
Share COVID-19 resources with your plan members:CVS Health’s “What you need to know about the new coronavirus (COVID-19) outbreak”: The CDC’s Guide “What to Do if You Are Sick with coronavirus Disease 2019 (COVID-19): |
As the COVID-19 outbreak evolves, we will continue to monitor and inform you and your plan members as necessary. Please reach out directly to your Account Team if you have any questions.
